CELLID
Korea - SeoulBiotechnology
Focus: CELLID is a Korean-headquartered immunotherapeutic vaccine biotech focused on infectious diseases and cancer vaccines, operating at pre-revenue stage with a pipeline of early-stage candidates.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About CELLID
AI assessmentNot HiringNo open roles listed right now. Follow CELLID to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AdCLD-CoV19-1
Covid19Clinical Trials (1)
NCT05047692Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
Phase 1Help build intelligence for CELLID
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.